Thomas Balzer

2.5k total citations
28 papers, 1.7k citations indexed

About

Thomas Balzer is a scholar working on Radiology, Nuclear Medicine and Imaging, Materials Chemistry and Epidemiology. According to data from OpenAlex, Thomas Balzer has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Materials Chemistry and 8 papers in Epidemiology. Recurrent topics in Thomas Balzer's work include MRI in cancer diagnosis (15 papers), Lanthanide and Transition Metal Complexes (14 papers) and Advanced MRI Techniques and Applications (12 papers). Thomas Balzer is often cited by papers focused on MRI in cancer diagnosis (15 papers), Lanthanide and Transition Metal Complexes (14 papers) and Advanced MRI Techniques and Applications (12 papers). Thomas Balzer collaborates with scholars based in Germany, United States and France. Thomas Balzer's co-authors include Peter Reimer, P. E. Peters, Bernd Tombach, Heike E. Daldrup‐Link, EJ Rummeny, T. Berns, Kohkan Shamsi, Renate Hammerstingl, Thomas J. Vogl and Wolf O. Bechstein and has published in prestigious journals such as Radiology, American Journal of Neuroradiology and Journal of Magnetic Resonance Imaging.

In The Last Decade

Thomas Balzer

27 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Balzer Germany 18 932 804 597 445 143 28 1.7k
T Staks Germany 11 492 0.5× 366 0.5× 318 0.5× 271 0.6× 109 0.8× 18 1.0k
Thomas Balzer Germany 9 471 0.5× 485 0.6× 353 0.6× 194 0.4× 347 2.4× 14 1.2k
Yikai Xu China 22 721 0.8× 283 0.4× 113 0.2× 250 0.6× 280 2.0× 77 1.5k
Josy Breuer Germany 16 916 1.0× 1.1k 1.4× 818 1.4× 273 0.6× 38 0.3× 28 1.7k
O Söllner Germany 7 300 0.3× 443 0.6× 243 0.4× 71 0.2× 151 1.1× 14 856
Nathalie Siauve France 27 800 0.9× 168 0.2× 133 0.2× 141 0.3× 218 1.5× 78 1.9k
K.-J. Wolf Germany 12 341 0.4× 205 0.3× 155 0.3× 105 0.2× 135 0.9× 25 697
C J Fretz United States 7 327 0.4× 149 0.2× 123 0.2× 183 0.4× 72 0.5× 9 660
W R Press Germany 7 379 0.4× 146 0.2× 140 0.2× 299 0.7× 50 0.3× 12 624

Countries citing papers authored by Thomas Balzer

Since Specialization
Citations

This map shows the geographic impact of Thomas Balzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Balzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Balzer more than expected).

Fields of papers citing papers by Thomas Balzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Balzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Balzer. The network helps show where Thomas Balzer may publish in the future.

Co-authorship network of co-authors of Thomas Balzer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Balzer. A scholar is included among the top collaborators of Thomas Balzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Balzer. Thomas Balzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boyken, Janina, Jessica Lohrke, Joerg Neddens, et al.. (2024). Gadolinium Presence in Rat Skin: Assessment of Histopathologic Changes Associated with Small Fiber Neuropathy. Radiology. 310(1). e231984–e231984. 4 indexed citations
2.
Michaely, Henrik J., Manuela Aschauer, Hannes Deutschmann, et al.. (2016). Gadobutrol in Renally Impaired Patients. Investigative Radiology. 52(1). 55–60. 41 indexed citations
3.
Endrikat, Jan, et al.. (2015). Safety of gadoxetate disodium: Results from the clinical phase II–III development program and postmarketing surveillance. Journal of Magnetic Resonance Imaging. 42(3). 634–643. 15 indexed citations
4.
5.
Balzer, Thomas, et al.. (2005). Interference of Gadolinium-Containing Contrast-Enhancing Agents With Colorimetric Calcium Laboratory Testing. Investigative Radiology. 40(8). 521–525. 22 indexed citations
6.
Bluemke, David A., Dushyant V. Sahani, Marco Amendola, et al.. (2005). Efficacy and Safety of MR Imaging with Liver-specific Contrast Agent: U.S. Multicenter Phase III Study. Radiology. 237(1). 89–98. 189 indexed citations
7.
Hammerstingl, Renate, Stephan Zangos, W. Schwarz, et al.. (2002). Contrast-Enhanced MRI of Focal Liver Tumors Using a Hepatobiliary MR Contrast Agent. Academic Radiology. 9(1). S119–S120. 23 indexed citations
8.
Reimer, Peter, Felipe Martins Müller, Christian Marx, & Thomas Balzer. (2002). Evaluation of the Time Window for Resovist-Enhanced T2-Weighted MRI of the Liver. Academic Radiology. 9(2). S336–S338. 10 indexed citations
9.
Zangos, Stephan, R Hammerstingl, Matthias Mack, et al.. (2001). Renales Anreicherungsverhalten und Elimination des hepatobiliären Kontrastmittels Gd-EOB-DTPA in der Magnetresonanztomographie. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 173(11). 1034–1040. 5 indexed citations
10.
Shamsi, Kohkan, et al.. (1998). Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.. Radiology. 206(2). 365–371. 46 indexed citations
11.
Kopp, Andreas F., Michael Laniado, F. Dammann, et al.. (1997). MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties.. Radiology. 204(3). 749–756. 75 indexed citations
12.
Reimer, Peter, Christian Marx, Ernst J. Rummeny, et al.. (1997). SPIO‐enhanced 2D‐TOF MR angiography of the portal venous system: Results of an intraindividual comparison. Journal of Magnetic Resonance Imaging. 7(6). 945–949. 33 indexed citations
13.
Lemke, A.-J., B. Sander, Thomas Balzer, et al.. (1997). Sicherheit und Nutzen von Gadobutrol bei Patienten mit zerebralen Tumoren (Phase-III-Studie). RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 167(12). 591–598. 20 indexed citations
14.
Reimer, Peter, EJ Rummeny, Kohkan Shamsi, et al.. (1996). Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.. Radiology. 199(1). 177–183. 252 indexed citations
15.
Balzer, Thomas, et al.. (1996). Results of a multicenter phase II clinical trial with a susceptibility contrast medium for magnetic resonance imaging of the liver. Academic Radiology. 3. S417–S419. 6 indexed citations
16.
Vogl, Thomas J., Sherko Kümmel, Renate Hammerstingl, et al.. (1996). Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.. Radiology. 200(1). 59–67. 388 indexed citations
17.
Reimer, Peter, Bernd Tombach, Heike E. Daldrup‐Link, et al.. (1996). Neue MR-Kontrastmittel in der Leberdiagnostik Erste klinische Ergebnisse mit hepatobiliärem Eovist® (Gadolinium-EOB-DTPA) und RES-spezifischem Resovist® (SH U 555 A). Der Radiologe. 36(2). 124–133. 17 indexed citations
18.
Reimer, Peter, EJ Rummeny, Heike E. Daldrup‐Link, et al.. (1995). Clinical results with Resovist: a phase 2 clinical trial.. Radiology. 195(2). 489–496. 150 indexed citations
19.
Witzel, L, et al.. (1991). Identification of patients at high risk for colorectal carcinoma from biopsy studies of the apparently normal colorectal mucosa.A multivariate analysis. European Journal of Clinical Investigation. 21(3). 295–302. 4 indexed citations
20.
Balzer, Thomas, et al.. (1988). Changes in the lectin‐binding pattern of PNA‐agglutinin and UEA1 during the DMH‐induced carcinogenesis in the normal appearing colonic mucosa of the rat. European Journal of Clinical Investigation. 18(2). 196–201. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T Staks Breakdown of academic impact, for papers by Thomas Balzer Breakdown of academic impact, for papers by Yikai Xu Breakdown of academic impact, for papers by Josy Breuer Breakdown of academic impact, for papers by O Söllner Breakdown of academic impact, for papers by Nathalie Siauve Breakdown of academic impact, for papers by K.-J. Wolf Breakdown of academic impact, for papers by C J Fretz Breakdown of academic impact, for papers by W R Press
Rankless by CCL
2026